title: Regarding "Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions".
authors.forename: Shiva
authors.initials: S
authors.lastname: Dindyal
authors.forename: Paritosh
authors.initials: P
authors.lastname: Sharma
authors.forename: Constantinos
authors.initials: C
authors.lastname: Kyriakides
mesh_terms: D000800:Angioplasty, Balloon / Q000009:adverse effects*; D001157:Arterial Occlusive Diseases / Q000503:physiopathology / Q000628:therapy*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D000077407:Cilostazol; D003251:Constriction, Pathologic; D005260:Female; D005263:Femoral Artery / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D008297:Male; D011150:Popliteal Artery / Q000187:drug effects* / Q000503:physiopathology; D012107:Research Design; D055502:Secondary Prevention; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome; D014654:Vascular Patency / Q000187:drug effects
chemical_list: D002317:Cardiovascular Agents; D013777:Tetrazoles; D000077407:Cilostazol